Answers are grounded in this paper and cite their sources.
BACKGROUND: Cystitis is the most common clinical manifestation of urinary tract infection (UTI) in women. AIM: The current study intends to assess the effectiveness of CO2 micro-ablative vaginal laser therapy in the treatment of recurrent cystitis RC. METHODS: A total of 75 women were divided into 2 Groups: Group 1 included 34 women (22 were menopausal women and 12 were non-menopausal women) with bacterial cystitis who were positive to urine culture analysis. The Group 2 included 41 women (34 were menopausal women and 7 were nonmenopausal women) with interstitial cystitis who were negative for urine culture analysis. Patients received three treatment sessions with a dual-wavelength (10600 nm/1540 nm) laser system. A visual analog scale (VAS) evaluation, ranging from 0 to 10, was administered to assess baseline and post-laser treatment urinary symptoms associated with cystitis. Concerning IUS (stress urinary incontinence) and Urgency score measurements, a VAS ranging from 0 to 5 was used. The O'Leary-Sant Interstitial Cystitis Symptom Index (ICSI) was used as treatment outcome measures. RESULTS: In both groups, a significant reduction in the average number of cystitis episodes after treatment was observed and the VAS scale showed a significant reduction in pre- and post-treatment symptoms. VAS results for patients' satisfaction and expectations showed positive outcomes revealing that more than 90% of patients were satisfied following the treatment. CONCLUSIONS: CO2 vaginal laser may represent an advantageous therapeutic approach to treating recurrent cystitis.
No takes yet. Share an insight, caveat, or question.
Filippini et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: